02:35 AM EDT, 09/04/2026 (MT Newswires) -- Medical technology company Nexstim (NXTMH.HE) secured an order for its NBS 6 system from a university hospital in Europe. The new customer plans to use the system primarily for pre-procedural brain mapping, with the option to expand into therapeutic applications, according to a Friday release.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.